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The adaptive behavior of human beings is usually supported by rapid monitoring of outstanding events in the environment. Some
investigators have suggested that a primary attention deficit might trigger symptoms of schizophrenia. In addition, researchers
have long discussed the relationship between schizophrenia and the schizophrenia-like psychosis of epilepsy (SLPE). On the
basis of these considerations, the objective of the present study was to investigate attention performance of patients with both
disorders. Patient age was 18 to 60 years, and all patients had received formal schooling for at least four years. Patients were
excluded if they had any systemic disease with neurologic or psychiatric comorbidity, or a history of brain surgery. The computer-
assisted TAVIS-2R test was applied to all patients and to a control group to evaluate and discriminate between selective,
alternating and sustained attention. The TAVIS-2R test is divided into three parts: one for selective attention (5 min), the second
for alternating attention (5 min), and the third for the evaluation of vigilance or sustained attention (10 min). The same computer
software was used for statistical analysis of reaction time, omission errors, and commission errors. The sample consisted of 36
patients with schizophrenia, 28 with interictal SLPE, and 47 healthy controls. The results of the selective attention tests for both
patient groups were significantly lower than that for controls. The patients with schizophrenia and SLPE performed differently in
the alternating and sustained attention tests: patients with SLPE had alternating attention deficits, whereas patients with
schizophrenia showed deficits in sustained attention. These quantitative results confirmed the qualitative clinical observations
for both patient groups, that is, that patients with schizophrenia had difficulties in focusing attention, whereas those with epilepsy
showed perseveration in attention focus.
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INTRODUCTION
Human beings are exposed to different types of stimuli
that must be detected and selected for later processing
and for the generation of responses. Therefore, individuals
must pay careful attention to the environment, as well as to
internal physical and psychological stimuli. Attention is
associated with alertness because certain situations re-
quire immediate and accurate responses. Several research-
ers have suggested that attention underlies all other cogni-
tive functions (1-3). An excessive amount of information,
which results from dispersive attention, makes it impos-
sible or difficult to understand facts or to identify what is
relevant. Also, prolonged focus on one fact rather than on
others may lead to distorted conclusions or loss of useful
and interesting opportunities.
Lezak (2) referred to attention as a set of several
capabilities or different processes that are associated with
how the human organism becomes receptive to stimuli and
how it processes and responds to either internal or exter-
nal stimuli. According to that study, four types of attention
were defined: a) selective attention: the capacity to select
one stimulus, either external or internal, from among sev-
eral others (including the absence of stimuli). It is the
capacity to focus on one or two stimuli or ideas while
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suppressing other stimuli that competitively disperse at-
tention; b) sustained attention (or vigilance): the capacity
to keep the focus of attention for a period of time. It refers
to readiness and to the ability to detect the next input
signal, which may not occur for a long period of time (4); c)
divided attention: the ability to respond to more than one
stimulus at the same time, or to multiple elements or
operations within one activity, such as a complex mental
activity; d) alternating attention: the capacity to respond to
repeated changes in focus.
Butler and Braff (5) suggested that a primary attention
deficit might trigger symptoms of schizophrenia, such as
paranoid-type delusions, which may be understood as
inadequate attempts to integrate abnormal experiences.
The adaptive behavior of human beings is usually sup-
ported by rapid monitoring of outstanding events in the
environment, which include threatening stimuli. Patients
with persecutory delusions, however, show a marked bias
towards detecting stimuli associated with threats and to-
wards recalling threatening episodes (6,7). Excessive at-
tention is directed at threatening stimuli when the indi-
vidual is experiencing delusions, but not after recovery (8).
When stimuli in the form of photographs of neutral, threat-
ening or ambiguous social scenes were presented to pa-
tients with schizophrenia and persecutory delusion, they
rapidly identified the threatening stimuli on the photo-
graphs. When photographs with ambiguous scenes were
used, patients with schizophrenia and persecutory delu-
sions took less time to identify threatening scenes than
patients with schizophrenia and non-persecutory delu-
sions or healthy individuals (9). The slower response of
patients with schizophrenia may be associated with a
decrease in alertness.
In 1963, Slater et al. (10) reviewed a number of cases
that became landmarks in the studies of psychoses in
patients with epilepsy. In 1968, Reynolds (11) conducted
an analysis of clinical aspects and referred to the three
most important hypotheses found in the literature: 1) that
the two disorders are biologically antagonistic; 2) that they
have a biological affinity, or 3) that any association be-
tween the two is completely fortuitous. In 1991, Toone (12)
summarized some generally accepted characteristics of
what has been called schizophrenia-like psychosis of epi-
lepsy (SLPE). In the literature, SLPE is described as chronic
and/or recurrent interictal psychotic episodes of a schizo-
phreniform type with delusions, hallucinations, thought
disorder, disorganized behavior, relative absence of cata-
tonic symptoms, mood swings, avolition, affective flatten-
ing (less intense than in schizophrenia), persistence of
psychotic symptoms, suicide attempts, multiple hospital-
izations, and generalized impaired functioning (13).
These two diseases have different prevalence rates:
schizophrenia affects about 1% of the general population,
whereas the rate of epileptic psychoses ranges from 3 to
7.1% (13).
Several investigators have studied attention and atten-
tion performance in either schizophrenia or epilepsy, but
few have focused on the comparison of these two dis-
eases. Mellers et al. (14) studied the neuropsychological
profiles of schizophrenia and SLPE in comparison with
healthy controls, and their results will be presented in the
discussion of our results.
The purpose of the present study was to investigate the
selective, sustained and alternating attention performance
of patients with schizophrenia and patients with SLPE
compared to healthy control subjects. Our initial hypo-
thesis was that the attentional capacity of patients with
schizophrenia would be similar to that of patients with
SLPE.
PATIENTS AND METHODS
Patients included in the study had a confirmed diagno-
sis of schizophrenia or of partial or generalized epilepsy
associated with interictal SLPE for longer than six months;
all patients were stable at the time of inclusion. Patient age
was 18 to 60 years, and all patients had received formal
schooling for at least four years. Patients were excluded if
they had any systemic disease with neurologic or psychiat-
ric comorbidity, or a history of brain surgery. Healthy
control subjects were 18 to 60 years old, had at least four
years of schooling and did not have a history of psychiatric
disorders or organic or systemic diseases.
Schizophrenia was diagnosed according to the criteria
established in the Diagnostic and Statistical Manual of
Mental Disorders, 4th edition (DSM-IV) (15). The diagno-
sis of schizophrenia was confirmed by the presentation of
36 vignettes to two independent psychiatrists experienced
in the treatment of schizophrenia. Epilepsy was diagnosed
according to the criteria established in the Classification of
Epileptic Seizures (16), and the Classification of Epilep-
sies and Epileptic Syndromes (17) of the Commission on
Classification and Terminology of the International League
Against Epilepsy. Interictal SLPE was diagnosed accord-
ing to the Pond Classification (18). All the healthy controls
underwent psychiatric evaluation conducted by one of the
authors to exclude a history of psychiatric symptoms ac-
cording to the criteria established in the DSM-IV.
The research protocol was approved by the Research
Ethics Committee of Universidade Federal de São Paulo
(EPM, UNIFESP) and written informed consent was ob-
tained from all participants.
Patients with schizophrenia were recruited in the out-
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patient service of the Schizophrenia Program of the De-
partment of Psychiatry of the Universidade Federal de São
Paulo (UNIFESP), São Paulo, SP, Brazil. Patients with
epilepsy were recruited at two services: a) the outpatient
clinic of the Service of Investigation and Treatment of
Epilepsies of the Neurology and Neurosurgery Depart-
ment of UNIFESP, and b) the outpatient service of the
Epilepsy and Psychiatry Project (PROJEPSI) of the Insti-
tute of Psychiatry at Hospital de Clínicas, School of Medi-
cine, Universidade de São Paulo, São Paulo, SP, Brazil.
Healthy controls were selected from two groups of volun-
teers: firefighters of different ranks from the Fire Depart-
ment of São Paulo, and parents of students in a São Paulo
school. Firefighters were examined when not on duty call,
when their attention was not particularly increased by their
work.
All participants took the computer-assisted TAVIS-2R
test to evaluate attention (19) and the Raven’s Progressive
Matrices test (20) to assess intelligence.
The computer-assisted TAVIS-2R test is divided into
three parts: one for selective attention (5 min), the second
for alternating attention (5 min), and the third for the evalu-
ation of vigilance or sustained attention (10 min). In this
test, all symbols are familiar: tic-tac-toe symbols in task 1
(selective attention); colors and basic geometric shapes in
task 2 (alternating attention), and a small solid circle in task
3 (sustained attention). In task 1, geometric shapes suc-
cessively appear one by one at 1-s intervals and remain on
the screen until the screen is full. The test-taker should
press a joystick button each time the shape previously
agreed upon with the examiner appears on the screen. In
task 2, pairs of geometric shapes (squares, triangles or
circles in yellow, red or blue) appear on the screen at
random and the test-taker receives alternate orders to
press the button when either a pair of equal shapes or a
pair of equal colors appears on the screen. In task 3, the
screen is black for 10 min, and the test-taker is told to press
the button only when a small solid red circle appears on the
screen, which happens sporadically and unpredictably on
different parts of the screen. The same computer software
was used for statistical analysis of reaction time, omission
errors and commission errors.
The Raven test evaluates the capacity to establish
adequate strategies to solve problems according to an
essentially visual (nonverbal) pattern of functioning. Test
results are not affected by the patient’s educational back-
ground and do not include verbal aspects that may lead to
translation distortions or biases secondary to vocabulary,
which is dependent on socioeconomic status. This test is
widely used to evaluate intelligence (21,22) and is the
standard tool used to validate associated tests.
The following questionnaire was applied for the evalu-
ation of all healthy controls. 1) Have you ever received
treatment for any mental disorder? 2) Have you experi-
enced or are you currently experiencing moments of psy-
chological tension that have compromised or interrupted
your daily life activities? 3) Do you have any difficulty to pay
attention to or focus attention on what you are doing? 4) Do
you have any memory problems? 5) Healthy controls also
answered questions evaluating symptoms of depressive
or hypomanic syndromes. 6) Neurologic and clinical his-
tory was recorded. 7) A free conversation was established
to identify possible current psychopathologic symptoms. If
any of these items pointed to positive answers (symptom
or treatment), the individual was excluded from the study,
even when that made the volunteer feel disappointed.
One-way ANOVA was used for descriptive statistical
analysis of the data, followed by Bonferroni correction to
identify significant differences between variables. The Stu-
dent t-test or the Mann-Whitney test was used for some of
the variables. Some variables were compared according
to crude score percentiles in the population (Raven test),
and the other variables were compared according to their
crude scores. Next, univariate linear regression was used
for all scores before multiple linear regression analysis.
Further statistical analyses were conducted using multiple
linear regression, a stepwise linear analysis, adjusting for
age, schooling and intelligence. The socioeconomic status
of all patients and healthy controls was middle or low-
middle class.
RESULTS
The study sample consisted of 111 subjects, 36 with
schizophrenia, 28 with interictal SLPE, and 47 healthy
controls. Table 1 shows that patients with epilepsy were
significantly older than patients with schizophrenia and
healthy controls and that their educational and intelligence
levels were lower. Age and schooling of patients with
schizophrenia did not differ significantly from those of
healthy controls, but their intelligence level was lower.
Levels of intelligence established according to the Raven
test are different from those established by the IQ test, and
the highest possible score is 50 points.
Multiple regression analysis of the results of the atten-
tion tests was used to compare both patient groups and
healthy controls (Tables 2 and 3), as well as patient groups
to each other (Table 4). All analyses were adjusted for age,
schooling and intelligence level.
Table 2 shows that patients with schizophrenia had
selective and sustained attention deficits compared to the
healthy population. The number of omission errors was
higher in the selective and sustained attention tasks.
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Table 1. Age, schooling and intelligence level of patients with schizophrenia, patients with interictal schizophrenia-like
psychosis of epilepsy, and healthy controls.
 SCH (N = 36) SLPE (N = 28) HC (N = 47) ANOVA
Age (years)
Mean ± SD 34.6 ± 9.5 39.9 ± 8.8* 33.9 ± 7.1 F = 4.989
Median 34 42 32 P = 0.008
Bonferroni Schizophrenia x epilepsy: -5.318; P = 0.040
Epilepsy x controls: 6.078; P = 0.009
Schooling (years)
Mean ± SD 10.8 ± 3.4 9.2 ± 3.6* 11.4 ± 3.2 F = 3.887
Median 11 10 11 P = 0.023
Bonferroni Epilepsy x controls: -2.233; P = 0.020
Intelligence level (percentile)
Mean ± SD 26.06 ± 23.31* 9.62 ± 9.89* 39.89 ± 24.03 F = 16.934
Median 20 5 35 P = 0.001
Bonferroni Schizophrenia x epilepsy 12.589; P < 0.011
Schizophrenia x controls -5.077; P = 0.016
Epilepsy x controls -17.665; P < 0.001
SCH = schizophrenia; SLPE = schizophrenia-like psychosis of epilepsy; HC = healthy controls.
Table 2. Comparison of TAVIS-2R scores for patients with schizophrenia and controls adjusted for age, schooling and intelligence
level.
Dependent RT- RT- RT- OE- OE- OE- CE- CE- CE-
variable selective alternating sustained selective alternating sustained selective alternating sustained
Age
B0 0.502 0.636 0.3 5.19 4.83 0.61 3.72 6.43 4.95
B1 -0.01 0.02 0.04 1.98 1.09 0.36 0.36 2.67 -5.21
SEM 0.01 0.02 0.05 0.935 0.571 0.525 0.848 0.782 3.358
P 0.26 0.44 0.462 0.038 0.061 0.491 0.669 0.001 0.126
Schooling
B2 0 -0.05 -0.06 -2.51 -1.39 -0.39 -0.89 -0.74 -0.03
SEM 0.01 0.02 0.052 0.95 0.58 0.53 0.86 0.79 3.39
P 0.96 0.01 0.277 0.01 0.019 0.464 0.303 0.353 0.993
IQ
B3 -0.02 -0.01 0.08 -1.74 -2.18 -0.74 -1.54 -3.3 -3.62
SEM 0.01 0.02 0.055 0.999 0.61 0.561 0.907 0.836 3.589
P 0.19 0.73 0.14 0.086 0.001 0.194 0.094 <0.001 0.317
Schizophrenia
B4 0 0.06 0.17 4.99 0.03 0.9 3.54 -0.37 7.75
SEM 0.01 0.02 0.053 0.961 0.587 0.54 0.872 0.804 3.453
P 0.85 0.01 0.002 <0.001 0.953 0.034 <0.001 0.649 0.028
B0 = regression coefficient for healthy controls; B1 = regression coefficient for age; B2 = regression coefficient for schooling; B3 =
regression coefficient for intelligence quotient (IQ); B4 = regression coefficient for schizophrenia; RT = reaction time; OE = omission
error; CE = commission error. Age: <36 years, ≥36 years; schooling: ≤11 years, >11 years; IQ: <25%, ≥25%.
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Table 3. Comparison of TAVIS-2R scores for patients with epilepsy and controls adjusted for age, schooling and intelligence level.
Dependent RT- RT- RT- OE- OE- OE- CE- CE- CE-
variable selective alternating sustained selective alternating sustained selective alternating sustained
Age
B0 0.48 0.64 0.4 4.99 5.28 0.05 2.97 6.83 0.49
B1 -0.02 -0.01 -0.06 0.92 1.37 -0.1 0.64 2.58 0.96
SEM 0.01 0.03 0.04 1.23 1.01 0.04 1.21 1.35 1.05
P 0.2 0.746 0.161 0.457 0.182 0.023 0.6 0.061 0.362
Schooling
B2 0 -0.04 -0.02 -0.63 -1.43 -0.03 -0.1 -0.29 0.45
SEM 0.01 0.03 0.04 1.23 1.01 0.04 1.21 1.35 1.04
P 0.969 0.22 0.689 0.613 0.162 0.507 0.937 0.829 0.666
IQ
B3 0.01 -0.01 -0.03 -2.07 -2.87 -0.01 -1.13 -4.01 -0.84
SEM 0.02 0.04 0.05 1.56 1.28 0.05 1.53 1.71 1.32
P 0.582 0.886 0.6 0.189 0.029 0.832 0.463 0.022 0.53
Epileptic psychosis
B4 -0.02 0.08 0.16 6.83 3.43 0.1 5.06 2.3 2.2
SEM 0.02 0.04 0.06 1.67 1.37 0.06 1.64 1.83 1.42
P 0.319 0.078 0.008 <0.001 0.015 0.076 0.003 0.063 0.126
B0 = regression coefficient for healthy controls; B1 = regression coefficient for age; B2 = regression coefficient for schooling; B3 =
regression coefficient for intelligence quotient (IQ); B4 = regression coefficient for schizophrenia-like epileptic psychosis; RT = reaction
time; OE = omission error; CE = commission error. Age: <36 years, ≥36 years; schooling: ≤11 years, >11 years; IQ: <25%, ≥25%.
Table 4. Comparison of TAVIS-2R scores for patients with schizophrenia and patients with epilepsy adjusted for age, schooling and
intelligence level.
Dependent RT- RT- RT- OE- OE- OE- CE- CE- CE-
variable selective alternating sustained selective alternating sustained selective alternating sustained
Age
B0 0.5 0.69 0.48 11.16 4.46 1.6 7.98 5.87 13.46
B1 -0.03 0.01 -0.02 1.36 1.13 0.49 0.06 2.22 -5.1
SEM 0.02 0.04 0.09 1.58 1.17 0.71 1.78 1.45 4.74
P 0.09 0.807 0.797 0.393 0.341 0.494 0.973 0.132 0.287
Schooling
B2 0.02 -0.11 -0.1 -2.97 -2.32 -0.59 -1.38 0.29 0.63
SEM 0.02 0.04 0.09 1.68 1.25 0.75 1.89 1.54 5.04
P 0.26 0.016 0.275 0.083 0.069 0.441 0.47 0.85 0.901
IQ
B3 -0.02 0.04 0.13 -3 -0.74 -1.25 -2.49 -3.18 -5.79
SEM 0.02 0.05 0.1 1.83 1.36 0.82 2.06 1.68 5.5
P 0.381 0.394 0.2 0.107 0.587 0.135 0.233 0.064 0.297
Epileptic psychosis
B4 -0.03 0.02 0.06 0.96 4.46 -1.65 0.87 2.1 -6.01
SEM 0.02 0.04 0.09 1.74 1.3 0.78 1.96 1.6 5.24
P 0.144 0.631 0.557 0.586 0.001 0.04 0.659 0.195 0.256
B0 = regression coefficient for healthy controls; B1 = regression coefficient for age; B2 = regression coefficient for schooling; B3 =
regression coefficient for intelligence quotient (IQ); B4 = regression coefficient for schizophrenia-like epileptic psychosis; RT = reaction
time; OE = omission error; CE = commission error. Age: <36 years, ≥36 years; schooling: ≤11 years, >11 years; IQ: <25%, ≥25%.
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Table 3 describes the comparison between patients
with epilepsy and healthy controls. Patients with epilepsy
had alternating and selective attention deficits, and omis-
sion errors were more frequent in the group of patients with
epilepsy in the three evaluations. The number of commis-
sion errors was different in all but the sustained attention
tasks.
The comparison of patients with epilepsy and patients
with schizophrenia (Table 4) revealed that there was no
statistically significant difference in the three measure-
ments of reaction times or in the frequency of commission
errors. A statistically significant difference was found for
omission errors in the alternating and sustained attention
tasks. Equivalent results were found for the two patient
groups in the selective attention task: both groups had a
greater number of omission and commission errors than
healthy controls (Tables 2 and 3), with no significant differ-
ence between patients with schizophrenia and patients
with epilepsy (Table 4).
The frequency of commission and omission errors
made by patients with schizophrenia in the alternating
attention task was not significantly different from those
made by healthy controls (Table 2). Patients in the epi-
lepsy group had a greater number of omission errors than
healthy controls, whereas the difference in the number of
commission errors was marginally significant (P < 0.06).
The number of omission errors for the alternating attention
was significantly greater in the epilepsy group than in the
schizophrenia group (Table 4). For sustained attention,
patients with schizophrenia made more omission and com-
mission errors than healthy controls (Table 2). No statisti-
cally significant difference was found between patients
with epilepsy and healthy controls in this task, although the
difference in the frequency of omission errors bordered
significance (P < 0.07).
Age at psychosis onset (mean: schizophrenia = 24.4
(7.6); epilepsy = 28.7 (11.3)) and duration of psychosis
(mean: schizophrenia = 10.2 (7.3); epilepsy = 11.2 (10.1))
were similar in the two groups of patients. Among the 28
patients with epilepsy, the development of psychotic symp-
toms preceded the onset of seizures in only 2 patients: for
1 of them by 15 years, and for the other by 5 years. For all
other patients in this group, epileptic seizures preceded
psychotic symptoms by a mean number of 15 years. Mean
number of hospitalizations was similar in the schizophre-
nia and epilepsy groups (1.6 (2.1) and 1.7 (3.4)). The
analysis of distribution according to gender showed that
1/3 of the patients were women in the schizophrenia group,
53.6% were women in the epilepsy group, and 38.3% in the
control group. The association between gender and affec-
tive deficit was not evaluated in this study.
Some patients were receiving monotherapy, but most
were also taking 2 or 3 psychotropic drugs; patients with
schizophrenia were being treated with typical or atypical
neuroleptic drugs, sometimes together with antianxiety
medication. Patients with epileptic psychosis were taking
one neuroleptic drug and one anticonvulsant drug, some-
times together with antianxiety medication. No patient was
taking topiramate.
DISCUSSION
In the tests of selective attention, both patient groups
made more omission and commission errors and had
significantly worse results than healthy controls, with no
difference between patient groups. Both groups showed
deficits in selective attention and, therefore, are likely to
face difficulties in adapting to their environment, as dis-
cussed in the introduction of this study. They may reach
wrong conclusions and distort reality, or may have great
difficulty in responding to external demands. In the alter-
nating attention tests, patients in the epilepsy group made
more omission errors than healthy controls, and the differ-
ence in the number of commission errors bordered signif-
icance (P < 0.06), perhaps due to a type II error. In this
case, the difficulty in alternating the focus of attention may
contribute to problems in interpersonal verbal interactions
and may slow the rhythm of fluency when discussing a
certain topic. In the sustained attention tasks, patients with
schizophrenia had worse results than healthy controls
both in numbers of omission and commission errors. As a
result of constant changes of attentional focus, perhaps
one of the factors responsible for poor persistence in
activities, patients are unable to start and maintain an
activity, or interpersonal verbal interactions, until comple-
tion of the activity. Patients with epilepsy showed a signifi-
cantly greater number of omission errors in the alternating
attention task but fewer omission errors in the sustained
attention task than patients with schizophrenia.
The results were obtained after multiple regression
analysis to rule out the effect of confounding factors:
patients with epilepsy had a significantly greater mean age
and fewer schooling years than those with schizophrenia
or healthy controls. However, these differences were found
in a clinically non-significant age bracket (mean age = 34 to
39 years), and schooling was equivalent to secondary
school.
The intelligence level of patients with epilepsy was
significantly lower than that of patients with schizophrenia
or healthy controls; patients with schizophrenia also had
significantly lower intelligence scores than healthy con-
trols. Low intelligence levels have been frequently de-
scribed in samples of nonpsychotic patients with epilepsy
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(23). If patients with epilepsy but no associated psychosis
tend to have a poorer intellectual performance, it is reason-
able to expect that those with psychosis may have an even
poorer performance. Chronic epilepsy is usually associ-
ated with less schooling.
Almost all patients were taking neuroleptic drugs, and
patients with epilepsy and psychosis were also taking
antiepileptic drugs. One of the limitations of our study was
that we were not able to reduce individual medication
doses to equivalent doses of one single standard psycho-
tropic drug (chlorpromazine) because no data about the
equivalence of atypical neuroleptic drugs are available,
and no comparisons with antiepileptic drugs have been
established. Moreover, these are the medications and
doses necessary to make patients more balanced and
clinically stable, and their cognitive profiles will reflect the
use of such medication when they present to a cognitive
rehabilitation team. No patient was taking a toxic dose of
medication.
Another limitation of our study was the use of the
TAVIS-2R test, which is still not a well-known and widely
accepted method, but which has the necessary basic
factors for good performance as a visual attention test: all
symbols are familiar (24), and the test differentiates types
of attention in each of its task more clearly than other
validated and widely used tests. The problem of lack of
validation was mitigated by the comparison of results with
a control group, as proposed by Engelberts et al. (25).
The results reportd by Mellers et al. (14) are similar to
our findings. These investigators studied the neuropsy-
chological profiles of similar groups of patients compared
with normal controls and nonpsychotic patients with epi-
lepsy and found almost identical profiles: psychotic pa-
tients had attention deficits, whereas nonpsychotic pa-
tients with epilepsy did not. Other cognitive functions, such
as intelligence level, memory and executive functions, did
not differ between groups. Nathaniel-James et al. (22)
compared similar groups and found that patients had al-
most the same cognitive performance profile. However,
our results, which separated different types of attention,
revealed differences between the diagnostic groups under
study.
The sustained and alternating attention performances
differed between the groups of patients with schizophrenia
and with epilepsy and psychosis, whereas selective atten-
tion deficits were equally found in both clinical conditions.
The comparison of qualitative clinical observations for
both patient groups revealed that these quantitative re-
sults were coherent, that is, that patients with schizophre-
nia had difficulties in focusing attention, whereas those
with epilepsy showed perseveration in the same focus.
Moreover, these results point to the fact that alternating
attention is the opposite of sustained attention, that is, the
greater the alternating attention, the lower the sustained
attention, and vice versa.
Our findings suggest several new paths for this line of
research: their correlation with positive or negative symp-
toms of psychoses or with the different types of epilepsy,
investigation of psychological and neurophysiological phe-
nomena in these conditions, and comparisons with other
mental, cognitive or affective functions. They also indicate
the need to validate the TAVIS-3R test (current version) for
use with adults.
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